A Japanese healthcare startup has begun clinical trials for a groundbreaking stem cell therapy designed to treat diabetes patients. This development highlights the growing intersection between traditional pharmaceutical research and emerging digital health technologies in Asia’s innovation ecosystem.
Source: Nikkei Asia Read Full Story